北美瞬时蛋白表达市场预测至 2031 年 - 区域分析 - 按产品类型(仪器、试剂、表达载体和感受态细胞)、应用(基因组研究、基因治疗、生物生产、癌症研究和药物开发)和最终用户(制药和生物技术公司、学术和研究机构以及临床研究组织)

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027


No. of Pages: 120    |    Report Code: TIPRE00022182    |    Category: Life Sciences

North America Transient Protein Expression Market
2023 年北美瞬时蛋白表达市场价值为 3.2414 亿美元,预计到 2031 年将达到 5.1873 亿美元;预计 2023 年至 2031 年的复合年增长率为 6.1%。

精准医疗人气飙升推动北美瞬时蛋白表达市场

随着医疗技术的进步,分子生物学技术在各种治疗或治疗方式的开发中的应用显着增加。基因组转录组信息有助于发现可用于监测疾病和预测其风险的生物标志物,是不同治疗方式的关键原则。由于可以获得大量有关人类遗传变异的信息,个性化或精准医疗的使用急剧增加。例如,mRNA 介导的治疗的特点是免疫原性降低、翻译效率更高、稳定性增强、药物安全性和瞬时蛋白表达,并且只有修饰的 mRNA 用于治疗应用,而不是整合整个宿主基因组。

制药和生物技术行业已经开发出各种创新技术来治疗癌症和神经退行性疾病。瞬时基因表达技术在神经创伤和神经退行性疾病相关研究方面取得了重大进展,从而导致了针对这些疾病的精准药物的引入。表观遗传学、遗传学和蛋白质组学的技术进步也支持了治疗由单细胞和多细胞疾病引起的各种遗传和罕见遗传疾病的治疗方法的发展。

2015 年在美国启动的精准医学计划加强了基因工程、基因组学和蛋白质组学的使用,从而增加了瞬时蛋白表达技术的使用。因此,持续的研发活动和日益增多的政府支持精准医学的举措推动了瞬时蛋白表达技术的采用。

北美瞬时蛋白表达市场概况

美国是世界上最大的瞬时蛋白表达市场,预计在预测期内将占据主导地位。由于生物制药领域的广泛研发活动、越来越多的初创企业参与蛋白质表达以及重组蛋白在治疗应用中的日益普及,预计该国的市场将增长。此外,各个细分市场的领导者的存在也促进了市场的扩张。

美国生物技术产业是世界上最大的产业。政府的支持和来自私营和公共部门的投资极大地促进了该国生物技术产业的发展。此外,生物制药领域已经非常发达,并不断寻求机会增强其产品组合。Illumina, Inc.、Regeneron Pharmaceuticals, Inc、Agilent Technologies, Inc、Vertex Pharmaceuticals 和 Biogen Inc. 等公司一直在医学、基因研究和生物工程领域工作;他们已经向市场推出了多种创新的医疗保健产品。

此外,COVID-19 大流行为瞬时蛋白表达市场提供了一些增长机会。生物技术公司加强了研究,以借助瞬时蛋白表达了解病毒的谱系、病毒性以及开发疫苗和其他治疗产品的潜力;因此,由于上述因素,预计瞬时蛋白表达市场将在预测期内继续增长。

北美瞬时蛋白表达市场收入和预测到 2031 年(百万美元)

北美瞬时蛋白表达市场细分

北美瞬时蛋白表达市场分为产品类型、应用、最终用户和国家。

根据产品类型,北美瞬时蛋白表达市场细分为仪器、试剂、表达载体和感受态细胞。仪器部分在 2023 年占据了最大的市场份额。

在应用方面,北美瞬时蛋白表达市场细分为基因组研究、基因治疗、生物生产、癌症研究和药物开发。基因组研究领域在 2023 年占据了最大的市场份额。

基于最终用户,北美瞬时蛋白表达市场细分为制药和生物技术公司、学术和研究机构以及临床研究组织。制药和生物技术公司部门在 2023 年占据了最大的市场份额。

按国家/地区划分,北美瞬时蛋白表达市场细分为美国、加拿大和墨西哥。美国在 2023 年占据了北美瞬时蛋白表达市场份额的主导地位。

Thermo Fisher Scientific Inc、Merck KGaA、QIAGEN NV、GenScript Biotech Corporation、Promega Corp、Takara Bio Inc、New England Biolabs、Agilent Technologies Inc、Mirus Bio LLC、Bio-Rad Laboratories Inc、Lonza Group AG 和 MaxCyte Inc 是北美瞬时蛋白表达市场的一些领先公司。

North America Transient Protein Expression Strategic Insights

Strategic insights for North America Transient Protein Expression involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-transient-protein-expression-market-strategic-framework.webp
Get more information on this report

North America Transient Protein Expression Report Scope

Report Attribute Details
Market size in 2019 US$ 329.67 Million
Market Size by 2027 US$ 502.86 Million
Global CAGR (2020 - 2027) 5.6%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By 产品类型
  • 仪器
  • 试剂
  • 表达载体
  • 感受态细胞
By 应用
  • 基因组研究
  • 基因治疗
  • 生物生产
  • 癌症研究
  • 药物开发
By 最终用户
  • 制药和生物技术公司
  • 学术和研究机构
  • 临床研究组织
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc.
  • MERCK KGaA
  • QIAGEN
  • GenScript
  • Promega Corporation
  • Takara Bio Inc.
  • MERIDIAN BIOSCIENCE, INC.
  • New England Biolabs
  • Agilent Technologies, Inc.
  • Mirus Bio LLC
  • Get more information on this report

    North America Transient Protein Expression Regional Insights

    The regional scope of North America Transient Protein Expression refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-transient-protein-expression-market-geography.webp
    Get more information on this report

    The List of Companies - North America Transient Protein Expression Market

    • Thermo Fisher Scientific Inc     
    • Merck KGaA                                      
    • QIAGEN NV                                          
    • GenScript Biotech Corporation     
    • Promega Corp                                     
    • Takara Bio Inc                                     
    • New England Biolabs             
    • Agilent Technologies Inc         
    • Mirus Bio LLC                                
    • Bio-Rad Laboratories Inc          
    • Lonza Group AG
    • MaxCyte Inc                                       
    Frequently Asked Questions
    How big is the North America Transient Protein Expression Market?

    The North America Transient Protein Expression Market is valued at US$ 329.67 Million in 2019, it is projected to reach US$ 502.86 Million by 2027.

    What is the CAGR for North America Transient Protein Expression Market by (2020 - 2027)?

    As per our report North America Transient Protein Expression Market, the market size is valued at US$ 329.67 Million in 2019, projecting it to reach US$ 502.86 Million by 2027. This translates to a CAGR of approximately 5.6% during the forecast period.

    What segments are covered in this report?

    The North America Transient Protein Expression Market report typically cover these key segments-

  • 产品类型 (仪器, 试剂, 表达载体, 感受态细胞)
  • 应用 (基因组研究, 基因治疗, 生物生产, 癌症研究, 药物开发)
  • 最终用户 (制药和生物技术公司, 学术和研究机构, 临床研究组织)
  • What is the historic period, base year, and forecast period taken for North America Transient Protein Expression Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Transient Protein Expression Market report:

  • Historic Period : 2017-2018
  • Base Year : 2019
  • Forecast Period : 2020-2027
  • Who are the major players in North America Transient Protein Expression Market?

    The North America Transient Protein Expression Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Thermo Fisher Scientific Inc.
  • MERCK KGaA
  • QIAGEN
  • GenScript
  • Promega Corporation
  • Takara Bio Inc.
  • MERIDIAN BIOSCIENCE, INC.
  • New England Biolabs
  • Agilent Technologies, Inc.
  • Mirus Bio LLC
  • Sino Biological Inc.
  • Who should buy this report?

    The North America Transient Protein Expression Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Transient Protein Expression Market value chain can benefit from the information contained in a comprehensive market report.